Viewing Study NCT07411703


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-04-05 @ 1:10 PM
Study NCT ID: NCT07411703
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2026-02-17
First Post: 2026-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Automated Trainer-Based Gait Rehabilitation for Hemiplegic Stroke Patients
Sponsor: Cheng-Hsin General Hospital
Organization:

Study Overview

Official Title: Gait Training for Hemiplegic Stroke Patients: Employing an Automated Trainer With Sensory Cues
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2026-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to evaluate the effectiveness of an automated mobile gait training device developed based on neurodevelopmental treatment (NDT) principles for patients with hemiplegic stroke. Stroke is a major cause of long-term disability, and many survivors experience impaired walking ability that affects their independence and daily functioning. NDT is a commonly used rehabilitation approach that emphasizes therapist-guided facilitation of normal movement patterns during gait training. However, conventional NDT gait training is physically demanding and time-consuming for therapists, which may limit the amount of repetitive gait practice patients can receive.

To address these limitations, this study introduces a power-assisted gait training device capable of reproducing key therapeutic interventions typically provided by therapists. The system uses synchronized dynamic assistance, auditory cues, and wearable inertial measurement units (IMUs) to support gait training on the ground and facilitate more natural and repetitive walking practice. The IMUs provide objective gait data that are used to evaluate changes in swing-phase symmetry, pelvic rotation amplitude, and walking speed.

The primary goal of this study is to assess changes in these gait parameters following training with the proposed NDT-based assistive device. The study plans to enroll 60 adult stroke survivors (aged 20 and older) over a 3-year period starting from March 26, 2025.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: